Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Combination therapy of Eicosapentaenoic acid and pitavastatin for Regression of coronary plaque evaluated by integrated backscatter intravascular ultrasonography; CHERRY study.

Trial Profile

Combination therapy of Eicosapentaenoic acid and pitavastatin for Regression of coronary plaque evaluated by integrated backscatter intravascular ultrasonography; CHERRY study.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 20 Dec 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Eicosapentaenoic acid (Primary) ; Pitavastatin (Primary)
  • Indications Acute coronary syndromes; Angina pectoris; Atherosclerosis; Hyperlipidaemia
  • Focus Pharmacodynamics; Registrational; Therapeutic Use
  • Acronyms CHERRY
  • Most Recent Events

    • 17 Dec 2017 Status changed from active, no longer recruiting to completed.
    • 09 Nov 2015 According to an Amarin Corporation media release, abstract of trial was published in Circulation.
    • 09 Nov 2015 According to an Amarin Corporation media release, results from this trial were presented at the American Heart Association Scientific Sessions.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top